These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15585478)

  • 1. Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET.
    Roivainen A; Rinne J; Virta J; Järvenpää T; Salomäki S; Yu M; Någren K
    J Nucl Med; 2004 Dec; 45(12):2032-9. PubMed ID: 15585478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
    Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
    J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.
    Snyder SE; Gunupudi N; Sherman PS; Butch ER; Skaddan MB; Kilbourn MR; Koeppe RA; Kuhl DE
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):132-43. PubMed ID: 11176278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
    Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
    Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
    Roivainen A; Någren K; Hirvonen J; Oikonen V; Virsu P; Tolvanen T; Rinne JO
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):671-82. PubMed ID: 19050880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.
    Toyohara J; Sakata M; Oda K; Ishii K; Ito K; Hiura M; Fujinaga M; Yamasaki T; Zhang MR; Ishiwata K
    J Nucl Med; 2013 Aug; 54(8):1302-7. PubMed ID: 23804329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
    Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
    Verhoeff NP; Wilson AA; Takeshita S; Trop L; Hussey D; Singh K; Kung HF; Kung MP; Houle S
    Am J Geriatr Psychiatry; 2004; 12(6):584-95. PubMed ID: 15545326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    Gjerløff T; Jakobsen S; Nahimi A; Munk OL; Bender D; Alstrup AK; Vase KH; Hansen SB; Brooks DJ; Borghammer P
    J Nucl Med; 2014 Nov; 55(11):1818-24. PubMed ID: 25324520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
    Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
    J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging butyrylcholinesterase activity in Alzheimer's disease.
    Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
    Ann Neurol; 2006 Dec; 60(6):746. PubMed ID: 17192935
    [No Abstract]   [Full Text] [Related]  

  • 12. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
    Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1927-30. PubMed ID: 15050629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
    Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA
    J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tomographic visualization of cholinesterase.
    Kuljis RO; Darvesh S; Greig NH; Geula C
    Ann Neurol; 2006 Dec; 60(6):745-6. PubMed ID: 17111417
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase.
    Macdonald IR; Reid GA; Joy EE; Pottie IR; Matte G; Burrell S; Mawko G; Martin E; Darvesh S
    Mol Imaging Biol; 2011 Dec; 13(6):1250-61. PubMed ID: 20976626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
    Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.